Soleil Securities downgrades Hospira (NYSE: HSP) from Buy to Hold. Price target lowered to $30 from $45-50 range.

This article: 143 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE